SARS-CoV-2-IN-25
PRODUCTS SPECIFICATIONS
DESCRIPTION
Overview
| MDL | - |
|---|---|
| Molecular Weight | 934.94 |
| Molecular Formula | C58H48O8P2 |
| SMILES | OP(OC1=C2C(C3C4=C(C2C3)C=C5C(C6C7=C(C5C6)C=CC=C7)=C4)=C(C8=C1C9C%10=CC(C%11CC%12C%13=C%11C=CC=C%13)=C%12C=C%10C8C9)OP(OCCC%14=CC=CC=C%14)(O)=O)(OCCC%15=CC=CC=C%15)=O |
Summary
SARS-CoV-2-IN-25 (Compound CP026) is a potent SARS-CoV-2 spike pseudoparticle transduction inhibitor with an IC 50 of 1.6 μM. SARS-CoV-2-IN-25 inhibits enveloped viruses and liposomes [1] .
IC50 & Target
In Vitro
SARS-CoV-2-IN-25 (Compound CP026) shows cytotoxicity with a CC
50
of 117.9 μM against Caco2 cells
[1]
.
SARS-CoV-2-IN-25 inhibits SARS-CoV-2, IAV, MeV, HIV-1 with IC
50
s of 1.8, 11.6, 1.9 and 1.5 μM, respectively. SARS-CoV-2-IN-25 inhibits liposome with an EC
50
of 2.6 μM
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.